Cargando…

Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells

On glucose restriction, epithelial cells can undergo entosis, a cell-in-cell cannibalistic process, to allow considerable withstanding to this metabolic stress. Thus, we hypothesized that reduced protein glycosylation might participate in the activation of this cell survival pathway. Glucose depriva...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyroššová, Petra, Aragó, Marc, Muñoz-Pinedo, Cristina, Viñals, Francesc, García-Rovés, Pablo M., Escolano, Carmen, Méndez-Lucas, Andrés, Perales, Jose C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402552/
https://www.ncbi.nlm.nih.gov/pubmed/36002449
http://dx.doi.org/10.1038/s41419-022-05177-x
_version_ 1784773201327292416
author Hyroššová, Petra
Aragó, Marc
Muñoz-Pinedo, Cristina
Viñals, Francesc
García-Rovés, Pablo M.
Escolano, Carmen
Méndez-Lucas, Andrés
Perales, Jose C.
author_facet Hyroššová, Petra
Aragó, Marc
Muñoz-Pinedo, Cristina
Viñals, Francesc
García-Rovés, Pablo M.
Escolano, Carmen
Méndez-Lucas, Andrés
Perales, Jose C.
author_sort Hyroššová, Petra
collection PubMed
description On glucose restriction, epithelial cells can undergo entosis, a cell-in-cell cannibalistic process, to allow considerable withstanding to this metabolic stress. Thus, we hypothesized that reduced protein glycosylation might participate in the activation of this cell survival pathway. Glucose deprivation promoted entosis in an MCF7 breast carcinoma model, as evaluated by direct inspection under the microscope, or revealed by a shift to apoptosis + necrosis in cells undergoing entosis treated with a Rho-GTPase kinase inhibitor (ROCKi). In this context, curbing protein glycosylation defects with N-acetyl-glucosamine partially rescued entosis, whereas limiting glycosylation in the presence of glucose with tunicamycin or NGI-1, but not with other unrelated ER-stress inducers such as thapsigargin or amino-acid limitation, stimulated entosis. Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M; PCK2) is upregulated by glucose deprivation, thereby enhancing cell survival. Therefore, we presumed that PEPCK-M could play a role in this process by offsetting key metabolites into glycosyl moieties using alternative substrates. PEPCK-M inhibition using iPEPCK-2 promoted entosis in the absence of glucose, whereas its overexpression inhibited entosis. PEPCK-M inhibition had a direct role on total protein glycosylation as determined by Concanavalin A binding, and the specific ratio of fully glycosylated LAMP1 or E-cadherin. The content of metabolites, and the fluxes from (13)C-glutamine label into glycolytic intermediates up to glucose-6-phosphate, and ribose- and ribulose-5-phosphate, was dependent on PEPCK-M content as measured by GC/MS. All in all, we demonstrate for the first time that protein glycosylation defects precede and initiate the entosis process and implicates PEPCK-M in this survival program to dampen the consequences of glucose deprivation. These results have broad implications to our understanding of tumor metabolism and treatment strategies.
format Online
Article
Text
id pubmed-9402552
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-94025522022-08-26 Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells Hyroššová, Petra Aragó, Marc Muñoz-Pinedo, Cristina Viñals, Francesc García-Rovés, Pablo M. Escolano, Carmen Méndez-Lucas, Andrés Perales, Jose C. Cell Death Dis Article On glucose restriction, epithelial cells can undergo entosis, a cell-in-cell cannibalistic process, to allow considerable withstanding to this metabolic stress. Thus, we hypothesized that reduced protein glycosylation might participate in the activation of this cell survival pathway. Glucose deprivation promoted entosis in an MCF7 breast carcinoma model, as evaluated by direct inspection under the microscope, or revealed by a shift to apoptosis + necrosis in cells undergoing entosis treated with a Rho-GTPase kinase inhibitor (ROCKi). In this context, curbing protein glycosylation defects with N-acetyl-glucosamine partially rescued entosis, whereas limiting glycosylation in the presence of glucose with tunicamycin or NGI-1, but not with other unrelated ER-stress inducers such as thapsigargin or amino-acid limitation, stimulated entosis. Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M; PCK2) is upregulated by glucose deprivation, thereby enhancing cell survival. Therefore, we presumed that PEPCK-M could play a role in this process by offsetting key metabolites into glycosyl moieties using alternative substrates. PEPCK-M inhibition using iPEPCK-2 promoted entosis in the absence of glucose, whereas its overexpression inhibited entosis. PEPCK-M inhibition had a direct role on total protein glycosylation as determined by Concanavalin A binding, and the specific ratio of fully glycosylated LAMP1 or E-cadherin. The content of metabolites, and the fluxes from (13)C-glutamine label into glycolytic intermediates up to glucose-6-phosphate, and ribose- and ribulose-5-phosphate, was dependent on PEPCK-M content as measured by GC/MS. All in all, we demonstrate for the first time that protein glycosylation defects precede and initiate the entosis process and implicates PEPCK-M in this survival program to dampen the consequences of glucose deprivation. These results have broad implications to our understanding of tumor metabolism and treatment strategies. Nature Publishing Group UK 2022-08-24 /pmc/articles/PMC9402552/ /pubmed/36002449 http://dx.doi.org/10.1038/s41419-022-05177-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Hyroššová, Petra
Aragó, Marc
Muñoz-Pinedo, Cristina
Viñals, Francesc
García-Rovés, Pablo M.
Escolano, Carmen
Méndez-Lucas, Andrés
Perales, Jose C.
Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells
title Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells
title_full Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells
title_fullStr Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells
title_full_unstemmed Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells
title_short Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells
title_sort glycosylation defects, offset by pepck-m, drive entosis in breast carcinoma cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402552/
https://www.ncbi.nlm.nih.gov/pubmed/36002449
http://dx.doi.org/10.1038/s41419-022-05177-x
work_keys_str_mv AT hyrossovapetra glycosylationdefectsoffsetbypepckmdriveentosisinbreastcarcinomacells
AT aragomarc glycosylationdefectsoffsetbypepckmdriveentosisinbreastcarcinomacells
AT munozpinedocristina glycosylationdefectsoffsetbypepckmdriveentosisinbreastcarcinomacells
AT vinalsfrancesc glycosylationdefectsoffsetbypepckmdriveentosisinbreastcarcinomacells
AT garciarovespablom glycosylationdefectsoffsetbypepckmdriveentosisinbreastcarcinomacells
AT escolanocarmen glycosylationdefectsoffsetbypepckmdriveentosisinbreastcarcinomacells
AT mendezlucasandres glycosylationdefectsoffsetbypepckmdriveentosisinbreastcarcinomacells
AT peralesjosec glycosylationdefectsoffsetbypepckmdriveentosisinbreastcarcinomacells